Evidence map›Paper›PMID 40292246›Full record

Review3 Biotech2025

Emerging ultrafast technologies in biotechnology.

Israt Jahan, Mohammad Harun-Ur-Rashid, Mohammed S Almuhayawi, Soad K Al Jaouni, Samy Selim

Abstract readReview
In one paragraph

Review in 3 Biotech, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Israt JahanAir Quality and Environmental Pollution Research Laboratory (AQEPRL), Centre for Advanced Research in Sciences (CARS), University of Dhaka, 1000, Dhaka, Bangladesh.
Mohammad Harun-Ur-RashidDepartment of Chemistry, International University of Business Agriculture and Technology (IUBAT), Dhaka, 1230 Bangladesh.
Mohammed S AlmuhayawiDepartment of Clinical Microbiology and Immunology, Faculty of Medicine, King Abdulaziz University, 21589 Jeddah, Saudi Arabia.
Soad K Al JaouniDepartment of Hematology/Oncology, Yousef Abdulatif Jameel Scientific Chair of Prophetic Medicine Application, Faculty of Medicine, King Abdulaziz University, 21589 Jeddah, Saudi Arabia.
Samy SelimDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences,, Jouf University, 72388 Sakaka, Saudi Arabia.ORCID 0000-0003-4025-8586

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review highlights the transformative applications of ultrafast technologies in biotechnology, focusing on their ability to provide real-time visualization and precise manipulation of biomolecular processes. Femtosecond lasers have enhanced precision in gene editing, minimizing off-target effects, while ultrafast spectroscopy has advanced understanding of protein folding pathways, enzymatic activity, and energy transfer mechanisms. Notable findings include the identification of protein folding intermediates linked to misfolding diseases, improved insights into enzymatic catalysis through hydration studies, and the development of real-time monitoring systems for CRISPR gene editing. Imaging innovations such as pump-probe microscopy and Coherent Anti-Stokes Raman Scattering (CARS) enable high-resolution observation of cellular dynamics, intracellular signaling, and neural activity. Furthermore, attosecond spectroscopy has provided unprecedented insights into ultrafast electron dynamics and charge migration. Integrating ultrafast technologies with AI and nanotechnology has accelerated advances in diagnostics, personalized medicine, and synthetic biology, driving breakthroughs in drug discovery, targeted therapeutics, and regenerative medicine. Despite challenges such as photodamage, integration with complex biological systems, and ethical considerations, ongoing advancements in ultrafast technologies are set to revolutionize biotechnology. These innovations hold immense potential for addressing critical challenges in healthcare and life sciences, enabling transformative progress in understanding and treating complex diseases.

Indexed as

BiotechnologyGene editingUltrafast imagingUltrafast lasersUltrafast spectroscopyUltrafast technologies

Identifiers

PMID40292246
PMCPMC12021753

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.